Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study

Authors :: Faverio, P
Rebora, P
Rossi, E
Del Giudice, S
Montanelli, F
Garzillo, L
Busnelli, S
Luppi, F
Valsecchi, M
Pesci, A
Faverio P.
Rebora P.
Rossi E.
Del Giudice S.
Montanelli F.
Garzillo L.
Busnelli S.
Luppi F.
Valsecchi M. G.
Pesci A.
Faverio, P
Rebora, P
Rossi, E
Del Giudice, S
Montanelli, F
Garzillo, L
Busnelli, S
Luppi, F
Valsecchi, M
Pesci, A
Faverio P.
Rebora P.
Rossi E.
Del Giudice S.
Montanelli F.
Garzillo L.
Busnelli S.
Luppi F.
Valsecchi M. G.
Pesci A.
Publication Year :: 2022
Abstract: Patients receiving N-acetyl-l-cysteine (NAC) during hospitalisation for #SARSCoV2 pneumonia and discharged alive present a significantly shorter length of hospital stay compared to those who did not receive NAC https://bit.ly/3l1QsVo.

Tools